Continuous blood glucose monitoring offers reliability and comfort to the patient. The occurrence of dangerous hypo glycaemia episodes is reduced, along with potential late onset diabetic complications caused by high blood glucose values. For these reasons health insurance companies are currently negotiating the inclusion of these devices in their approved formularies.
The FiberSense system from EyeSense GmbH does not measure glucose in the blood, but rather painlessly and safely in the subcutaneous interstitial fluid. A miniature fiber optic sensor, worn on the arm or abdomen, sends the monitored value wirelessly to the monitoring device device.
Via the monitoring device, the patient can see the current value, as well as the trend (rising, falling) and a historical chart of the last measured values.